Combination therapy
US-12161644-B2 · Dec 10, 2024 · US
This page is not indexed by search engines while we improve data quality.
Mei Pharma Inc patents in 2024
Mei Pharma Inc was listed as an assignee on 5 patent publications in 2024.
| Metric | Value |
|---|---|
| Company | Mei Pharma Inc |
| Year | 2024 |
| Patents | 5 |
Patents
Representative publications for Mei Pharma Inc in 2024.
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
US-12059422-B2 · Aug 13, 2024 · US
Voruciclib dosing regimens and methods of treatment including the same
US-2024197680-A1 · Jun 20, 2024 · US
Isoflavonoid compositions and methods for the treatment of cancer
US-2024165073-A1 · May 23, 2024 · US
Treatment of kras mutant cancers
US-2024016781-A1 · Jan 18, 2024 · US
Top CPC classifications
Most common classification codes for Mei Pharma Inc in 2024.
| CPC | Patents |
|---|---|
| A61P35/00 | 5 |
| A61K45/06 | 4 |
| A61K2300/00 | 3 |
| A61P35/02 | 3 |
| A61K31/4025 | 2 |
Related pages
Navigate to parent entity pages.